REQUEST A DEMO
Total
USD $0.00
Search more companies

Rigla OOO (OKPO:54743163) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Rigla OOO Profile Updated: May 15, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Russian Download a sample report

Rigla pharmacy chain was established in 2001 and is currently among the leaders of the retail pharmacy market. As of the end of 2006, Rigla operated 490 pharmacies across 24 Russian regions; the chain’s sales increased by 129% as compared with 2006 and now stand at USD 247 million, including Rx drugs. According to analytical agencies, the Company ranks 2nd among pharmacy chains in terms of sales and is on the list of top ten Russia’s retail chains in terms of growth rates according to the annual ratings compiled by the Kommersant Publishers.

Headquarters
Shosse Kashirskoe, 22, 4(1)
Moscow; Moscow; Postal Code: 115201

Contact Details: Purchase the Rigla OOO (OKPO:54743163) report to view the information.

Basic Information
Total Employees:
Purchase the Rigla OOO (OKPO:54743163) report to view the information.
Registered Capital:
Purchase the Rigla OOO (OKPO:54743163) report to view the information.
Incorporation Date:
July 04, 2000
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Apteka N181 OOO
100%
Novofarm OOO (OKPO:1901691)
100%
Aptechnaya Set Oz OOO
99.9997%
Company Performance
Financial values in the chart are available after Rigla OOO (OKPO:54743163) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
19.62%
Total operating revenue
19.62%
Operating profit (EBIT)
-9.45%
Net Profit (Loss) for the Period
9.34%
Total assets
21.07%
Total equity
1.29%
Operating Profit Margin (ROS)
0.49%
Net Profit Margin
-0.33%
Return on Equity (ROE)
2.08%
Debt to Equity Ratio
1.26%
Quick Ratio
-0.05%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?